BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 27522613)

  • 1. Strategies used for measuring long-term control in atopic dermatitis trials: A systematic review.
    Barbarot S; Rogers NK; Abuabara K; Aubert H; Chalmers J; Flohr C; Hanifin J; Naldi L; Margolis DJ; Paul C; Ridd MJ; Schuttelaar MA; Simpson E; Tauber M; Volke A; Weidinger S; Wilkes SR; Wollenberg A; Thomas KS
    J Am Acad Dermatol; 2016 Nov; 75(5):1038-1044. PubMed ID: 27522613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.
    Wahn U; Bos JD; Goodfield M; Caputo R; Papp K; Manjra A; Dobozy A; Paul C; Molloy S; Hultsch T; Graeber M; Cherill R; de Prost Y;
    Pediatrics; 2002 Jul; 110(1 Pt 1):e2. PubMed ID: 12093983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical tacrolimus for atopic dermatitis.
    Cury Martins J; Martins C; Aoki V; Gois AF; Ishii HA; da Silva EM
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009864. PubMed ID: 26132597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are Biologics Efficacious in Atopic Dermatitis? A Systematic Review and Meta-Analysis.
    Snast I; Reiter O; Hodak E; Friedland R; Mimouni D; Leshem YA
    Am J Clin Dermatol; 2018 Apr; 19(2):145-165. PubMed ID: 29098604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of treatment escalation as a definition of atopic eczema flares.
    Thomas KS; Stuart B; O'Leary CJ; Schmitt J; Paul C; Williams HC; Langan S
    PLoS One; 2015; 10(4):e0124770. PubMed ID: 25897763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of pimecrolimus cream 1% for the treatment of mild to moderate atopic dermatitis.
    Hebert AA
    Clin Ther; 2006 Dec; 28(12):1972-82. PubMed ID: 17296454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A starch, glycyrretinic, zinc oxide and bisabolol based cream in the treatment of chronic mild-to-moderate atopic dermatitis in children: a three-center, assessor blinded trial.
    Licari A; Ruffinazzi G; DE Filippo M; Castagnoli R; Marseglia A; Agostinis F; Puviani M; Milani M; Marseglia GL
    Minerva Pediatr; 2017 Dec; 69(6):470-475. PubMed ID: 29181960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug.
    Kapp A; Papp K; Bingham A; Fölster-Holst R; Ortonne JP; Potter PC; Gulliver W; Paul C; Molloy S; Barbier N; Thurston M; de Prost Y;
    J Allergy Clin Immunol; 2002 Aug; 110(2):277-84. PubMed ID: 12170269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different potencies of topical corticosteroids for a better treatment strategy in children with atopic dermatitis (the Rotterdam Eczema study): protocol for an observational cohort study with an embedded randomised open-label controlled trial.
    van Halewijn KF; Bohnen AM; van den Berg PJ; Pasmans SGMA; Bindels PJE; Elshout G
    BMJ Open; 2019 Jun; 9(6):e027239. PubMed ID: 31221882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review.
    Roekevisch E; Spuls PI; Kuester D; Limpens J; Schmitt J
    J Allergy Clin Immunol; 2014 Feb; 133(2):429-38. PubMed ID: 24269258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and cost-effectiveness of once-daily versus more frequent use of same potency topical corticosteroids for atopic eczema: a systematic review and economic evaluation.
    Green C; Colquitt JL; Kirby J; Davidson P; Payne E
    Health Technol Assess; 2004 Nov; 8(47):iii,iv, 1-120. PubMed ID: 15527669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonging Time to Flare in Pediatric Atopic Dermatitis: A Randomized, Investigator-Blinded, Controlled, Multicenter Clinical Study of a Ceramide-Containing Moisturizer.
    Ma L; Li P; Tang J; Guo Y; Shen C; Chang J; Kerrouche N
    Adv Ther; 2017 Dec; 34(12):2601-2611. PubMed ID: 29143926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of topical corticosteroids and topical calcineurin inhibitors for the treatment of atopic dermatitis in thin and sensitive skin areas.
    Draelos ZD
    Curr Med Res Opin; 2008 Apr; 24(4):985-94. PubMed ID: 18284804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review of Investigator Global Assessment (IGA) in atopic dermatitis (AD) trials: Many options, no standards.
    Futamura M; Leshem YA; Thomas KS; Nankervis H; Williams HC; Simpson EL
    J Am Acad Dermatol; 2016 Feb; 74(2):288-94. PubMed ID: 26685719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative).
    Chalmers JR; Simpson E; Apfelbacher CJ; Thomas KS; von Kobyletzki L; Schmitt J; Singh JA; Svensson Å; Williams HC; Abuabara K; Aoki V; Ardeleanu M; Awici-Rasmussen M; Barbarot S; Berents TL; Block J; Bragg A; Burton T; Bjerring Clemmensen KK; Creswell-Melville A; Dinesen M; Drucker A; Eckert L; Flohr C; Garg M; Gerbens LA; Graff AL; Hanifin J; Heinl D; Humphreys R; Ishii HA; Kataoka Y; Leshem YA; Marquort B; Massuel MA; Merhand S; Mizutani H; Murota H; Murrell DF; Nakahara T; Nasr I; Nograles K; Ohya Y; Osterloh I; Pander J; Prinsen C; Purkins L; Ridd M; Sach T; Schuttelaar ML; Shindo S; Smirnova J; Sulzer A; Synnøve Gjerde E; Takaoka R; Vestby Talmo H; Tauber M; Torchet F; Volke A; Wahlgren CF; Weidinger S; Weisshaar E; Wollenberg A; Yamaga K; Zhao CY; Spuls PI
    Br J Dermatol; 2016 Jul; 175(1):69-79. PubMed ID: 27436240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent trends in disease severity and quality of life instruments for patients with atopic dermatitis: A systematic review.
    Hill MK; Kheirandish Pishkenari A; Braunberger TL; Armstrong AW; Dunnick CA
    J Am Acad Dermatol; 2016 Nov; 75(5):906-917. PubMed ID: 27615798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pimecrolimus cream in the long-term management of atopic dermatitis in adults: a six-month study.
    Meurer M; Fölster-Holst R; Wozel G; Weidinger G; Jünger M; Bräutigam M;
    Dermatology; 2002; 205(3):271-7. PubMed ID: 12399676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placebo responses in randomized controlled trials for systemic therapy in atopic dermatitis: A systematic review and meta-analysis.
    Lee HH; Patel KR; Rastogi S; Singam V; Vakharia PP; Chopra R; Silverberg JI
    J Am Acad Dermatol; 2020 Jan; 82(1):62-71. PubMed ID: 31202874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review and meta-analysis of randomized clinical trials (RCTs) comparing topical calcineurin inhibitors with topical corticosteroids for atopic dermatitis: A 15-year experience.
    Broeders JA; Ahmed Ali U; Fischer G
    J Am Acad Dermatol; 2016 Aug; 75(2):410-419.e3. PubMed ID: 27177441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring long-term disease control in patients with atopic dermatitis: A validation study of well-controlled weeks.
    Langan SM; Stuart B; Bradshaw L; Schmitt J; Williams HC; Thomas KS
    J Allergy Clin Immunol; 2017 Dec; 140(6):1580-1586. PubMed ID: 28456619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.